William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Names 14 New Partners
-
UPDATE: William Blair Downgrades F5 Networks (FFIV) to Market Perform
-
Nutanix (NTNX) Checks Suggest Strong Q2 Billings Momentum - William Blair
-
The Economist to Host Third Annual Impact Investing Conference in New York
-
Everbridge, Inc. (EVBG) Prices 2.3M Share Common Offering at $55.25/Sh
-
Everbridge Announces Pricing of Public Offering of Common Stock
-
Everbridge, Inc. (EVBG) to Offer $125M in Common Stock
-
Everbridge Announces Proposed Public Offering of Common Stock
-
Form 40-17G WILLIAM BLAIR FUNDS
-
Berkshire Partners Announces New Director of Business Development
-
Holding(s) in Company
-
GE (GE): 'End of Apocalypse Scenarios Now at Hand' - William Blair
-
Holding(s) in Company
-
William Blair Starts The Hackett Group (HCKT) at Outperform
-
William Blair Starts Napco Security Technologies, Inc. (NSSC) at Outperform
-
William Blair Starts Mine Safety Appliances (MSA) at Market Perform
-
ICR Announces Cannabis Track and Panels at 2019 ICR Conference
-
ICR Announces Schedule and Panels for the 2019 ICR Conference
-
Pritzker Group Venture Capital names Sonia Nagar partner, announces other promotions
-
Holding(s) in Company
-
William Blair Downgrades Diplomat Pharmacy (DPLO) to Market Perform
-
Growpacker Inc. to Participate at the 21st Annual ICR Conference
-
MaxLinear, Inc. to Present at Upcoming Financial Conferences
-
Affiliates of CVC Fund VII Complete Tender Offer for All Outstanding Shares of ConvergeOne
-
Celgene Takeover Might Impact BeiGene's (BGNE) Tislelizumab Partnership - William Blair
-
Arlington Capital Partners Announces the Sale of Avalign Technologies
-
William Blair Starts OptimizeRX (OPRX) at Outperform
-
Form 497K WILLIAM BLAIR FUNDS
-
William Blair Upgrades EnerSys (ENS) to Outperform
-
TPG Capital backs BVI to Acquire PhysIOL Group SA
-
William Blair Downgrades Shire (SHPG) to Market Perform Following Takeda Merger
-
Warren Equity Announces Acquisition of StormTrap
-
The CapStreet Group Announces the Sale of symplr
-
Robertshaw Completes Acquisition of CastFutura S.p.A.
-
Robertshaw Completes Acquisition of CastFutura S.p.A
-
Pamplona Capital Management Acquires Controlling Interest in Latham Pool Products
-
ICR Announces Jeff Fromm as Keynote Speaker for Its 21st Annual Conference
-
Optimizerx Corporation (OPRX) Prices 2.1M Common Stock Offering by Shareholder at $10/Share
-
OptimizeRx Announces Pricing of Public Offering of Common Stock
-
OptimizeRx Announces Pricing of Public Offering of Common Stock
-
Biohaven Announces Closing Of $144M Public Offering Of Common Shares, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Optimizerx Corporation (OPRX) Announces 2.1M Share Common Stock Offering by Shareholder
-
OptimizeRx Announces Proposed Public Offering of Common Stock
-
OptimizeRx Announces Proposed Public Offering of Common Stock
-
Vanguard To Merge Growth Funds And Change Advisory Teams Of Three Stock Funds
-
Biohaven (BHVN) Prices 3.355M Share Offering at $37.25/Sh
-
Biohaven Announces Pricing of Public Offering of Common Shares
-
Orgenesis CEO Vered Caplan to Present at William Blair’s Biotech Focus Day Series: Cell and Gene Therapy Manufacturing
-
William Blair Downgrades Stitch Fix, Inc. (SFIX) to Market Perform
-
William Blair Starts Box, Inc. (BOX) at Outperform

